New insights into endothelial cell physiology and pathophysiology

Małgorzata Józkowiak1, Julia Niebora2, Dominika Domagała2

  • 1Division of Anatomy, Department of Human Morphology and Embryology, Wroclaw Medical University, Wroclaw, Poland; Department of Toxicology, Poznan University of Medical Sciences, Poznan, Poland; Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.

Endothelial cells, the gatekeepers of vascular permeability, play a pivotal role in vascular homeostasis by controlling inflammatory responses and hemostatic balance. However, their role is not limited to the circulatory system, since they also mediate organ function through numerous signaling pathways and cellular interactions. Recent studies have shown that endothelial cells not only constitute a heterogeneous population but also exhibit adaptive capacity, particularly in response to mechanical or biochemical stimuli. A growing body of research on endothelial cells also highlights their involvement in various pathological conditions, including cardiovascular diseases, inflammatory disorders, and cancer. Furthermore, endothelial progenitor cells represent a valuable therapeutic option in regenerative medicine, and ongoing clinical trials are investigating their use in the treatment of ischemic diseases, myocardial infarction, and organ fibrosis. This manuscript reviews the physiology and pathophysiology of endothelial cells, focusing on recent findings and clinical applications relevant to new therapeutic approaches.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
36